Sandra K. Barrett

Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.

Thomas H. Inge, Shelley K. Hoover, Sandra K. Barrett et al. · PubMed · 1992 · 128 citations

Life Sciences, Immunology, Oncology +17

Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity

Shelley K. Hoover, Sandra K. Barrett, Thomas M. T. Turk et al. · Cancer Immunology Immunotherapy · 1990 · 59 citations · Full text

Medicine, Immunology, Oncology +12

Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes

Thomas H. Inge, Kristin McCoy, Sandra K. Barrett et al. · The Journal of Immunology · 1992 · 45 citations

Life Sciences, Cell Biology, Immunology +16

Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for their in vitro generation from tumor-bearing host and immune spleens.

Harry D. Bear, K A Close, Sandra K. Barrett · PubMed · 1988 · 26 citations

Life Sciences, Immunology, Oncology +16

Sensitizing T-lymphocytes for adoptive immunotherapy by vaccination with wild-type or cytokine gene-transduced melanoma

Kenneth A. Lipshy, Paul J. Kostuchenko, Giselle G. Hamad et al. · Annals of Surgical Oncology · 1997 · 17 citations

Life Sciences, Immunology, Oncology +14